Named Patient Program for Mitomycin for Pyelocalyceal Solution

Conditions:   Urothelial Cancer of Renal Pelvis;   Urothelial Carcinoma of the Renal Pelvis and Ureter;   Urothelial Carcinoma Ureter;   Urothelial Carcinoma Ureter Recurrent;   Urothelial Carcinoma;   Urothelial Carcinoma Recurrent Intervention:   Drug: Mitomycin for pyelocalyceal solution Sponsors:   UroGen Pharma Ltd.;   Tanner Pharma Group Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials